# US 8,569,490 B2 · Intermediate and process for preparing entecavir using same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,569,490 B2
- Document ID: US8569490B2
- Status: Granted
- Kind: B2
- Application number: 13/140,640
- Filed: 2009-12-24
- Published: 2011-10-13
- Granted: 2013-10-29
- Earliest claimed: 2008-12-26
- Assignees: Hanmi Science Co., Ltd.
- Applicants: Jaeheon Lee; Gha-Seung Park; Jin Hee Kim; Ji Eun Lee; Chul Hyun Park; Tae Jin Choi; Eun-Ju Park; Cheol Kyung Kim; Eun Jung Lim; Young-Kil Chang; Gwan Sun Lee
- Inventors: Jaeheon Lee; Gha-Seung Park; Jin Hee Kim; Ji Eun Lee; Chul Hyun Park; Tae Jin Choi; Eun-Ju Park; Cheol Kyung Kim; Eun Jung Lim; Young-Kil Chang; Gwan Sun Lee
- Web page: https://patentgrep.com/patent/US8569490B2

## CPC

- C07D 473/18: one oxygen and one nitrogen atom, e.g. guanine
- A61P 31/12: Antivirals
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a novel, high-yield and low-cost method for preparing entecavir, [1-S-(1α,3α,4β)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one, an antiviral agent, and novel intermediates used therein.

## Claims

### Claim 1

A method of preparing entecavir of formula (1), comprising the steps of
(a) conducting olefination of an α-hydroxy ketone compound of formula (2) to obtain an exomethylene compound of formula (3);
(b) carrying out a Mitsunobu reaction of the exomethylene compound of formula (3) with a purine derivative to obtain a nucleoside compound of formula (4);
(c) removing the protecting groups of the nucleoside compound of formula (4) to obtain a compound of formula (5); and
(d) hydrolyzing the compound of formula (5):
wherein
R1 and R2 are each independently H or a hydroxy-protecting group, or R1 and R2 are fused together to form a cyclic hydroxy-protecting group;
R3 is selected from the group consisting of H, alkylsilyl, and allylsilyl; and
X is selected from the group consisting of chloro, iodo, and benzyloxy.

### Claim 2 (depends on 1)

The method of claim 1, wherein the hydroxy-protecting group is selected from the group consisting of trityl, benzyl, methoxybenzyl, p-nitrobenzyl, benzoyl, a substituted benzoyl, trimethylsilyl, triethylsilyl, isopropyldimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, thexyldimethylsilyl, allyl, methoxymethyl, (2-methoxyethoxy)methyl, and tetrahydropyranyl.

### Claim 3 (depends on 1)

The method of claim 1, wherein the cyclic hydroxy-protecting group is selected from the group consisting of benzylidene, naphthylidene, 4-phenylbenzylidene, cyclic acetal, cyclic ketal, cyclic carbonate, cyclic orthoester, and cyclic 1,3-(1,1,3,3-tetraisopropyl)disiloxanediyl.

### Claim 4 (depends on 1)

The method of claim 1, wherein the olefination is conducted by subjecting the α-hydroxy ketone compound of formula (2) to a reaction with a mixture of Nysted reagent and TiCl4, a Wittig reagent, or a Tebbe reagent.

### Claim 5 (depends on 1)

The method of claim 1, wherein the purine derivative is selected from the group consisting of a 2-amino-6-halopurine derivative of formula (12), a 6-O-benzylguanine derivative, and a mixture thereof:
wherein X is selected from the group consisting of chloro, iodo, and benzyloxy.

### Claim 6 (depends on 1)

The method of claim 1, wherein the compound of formula (2) is prepared by a method comprising the step of subjecting a ketone compound of formula (6) to a reaction with a sulfonate derivative in the presence of a base to obtain a silyl enolether of formula (7) and treating the silyl enolether of formula (7) with a peroxide:
wherein R1 to R3 are the same as described in claim 1.

### Claim 7 (depends on 6)

The method of claim 6, wherein the sulfonate derivative is selected from the group consisting of tert-butyldimethylsilyl trifluoromethanesulfonate, trimethylsilyl trifluoromethanesulfonate, triethylsilyl trifluoromethanesulfonate, and a mixture thereof.

### Claim 8 (depends on 1, 6)

The method of claim 6, wherein the compound of formula (6) is prepared by a method comprising the steps of
conducting a chiral reduction reaction of a cyclopentenone compound of formula (8) with borane dimethylsulfide in the presence of (R)-methyl-CBS (Corey-Bakshi-Shibata) catalyst to obtain a chiral cyclopentenol compound of formula (9);
subjecting the resulting chiral cyclopentenol compound of formula (9) to a reaction with a silane derivative in the presence of a base, or removing the protecting groups of the chiral cyclopentenol compound of formula (9) followed by treating with a carbonyl or an alcohol derivative to obtain a cyclopentene compound of formula (10);
subjecting the resulting cyclopentene compound of formula (10) to a reaction with a borane derivative to obtain a cyclopentanol compound of formula (11); and
carrying out an oxidation reaction by treating cyclopentanol compound of formula (11) with 1,1,1-triacetoxy-1,1-dihydro-1,2-benziodoxol-3-(1H)-one:
wherein R1 to R2 are the same as described in claim 1.

### Claim 9 (depends on 8)

The method of claim 8, wherein the silane derivative is selected from the group consisting of tert-butyldiphenylsilyl chloride, chlorotrimethylsilane, tert-butyldimethylchlorosilane, and a mixture thereof.

### Claim 10 (depends on 8)

The method of claim 8, wherein the carbonyl derivative is selected from the group consisting of naphthylaldehyde, naphthylaldehyde dimethylacetal, benzaldehyde, benzaldehyde dimethylacetal, 4-phenylbenzaldehyde, 4-phenylbenzaldehyde dimethylacetal, and a mixture thereof.